(Allergan plc)

	AGN latest price $121.8800 (-0.44%) ($120.6800 - $123.8600) on Fri. May. 31, 2019.
	Trend Analysis and Forecast
Average Daily Percentage Swing	1.7% (three month average)
RSI	22
Latest Price	$121.8800(-0.44%)
Stocks Behave Similarly	Similar Stock List
Daily Trend	AGN declines -2.5% a day on average for past five trading days.
Weekly Trend	AGN declines -4% a week on average for past two weeks.
Market Behavior	Broad based sell-off for large cap. Broad based sell-off for small cap.
Correlated ETFs	Broad market will support AGN advance at 0% a week (0% probability)   IBB(47%)    XLV(46%)    ARKG(45%)    IVE(45%)    IWD(45%)
Factors Impacting AGN price	AGN will decline at least -0.85% in a week (0% probabilities).   VXX(-38%)    VIXM(-23%)    TLT(-22%)    IFRA(-19%)    GDX(-5%)
Relative Volatility	(options are extremely cheap)
Market Trend Strength	-0.85% (StdDev 1.7%)
Hourly BBV	0 ()
Intraday Trend	0.6%

Resistance Level	$136.41
5 Day Moving Average	$127.38(-4.32%)
10 Day Moving Average	$132.78(-8.21%)
20 Day Moving Average	$136.41(-10.65%)
To recent high	-20.9%
To recent low	0%
Market Cap	$40.184b

Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following business segments: US Specialized Therapeutics; US General Medicine, and International. The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States. The US General Medicine segment involves Central Nervous System; Gastrointestinal; Women's Health; Anti-Infectives; and Diversified brands. The International segment comprises of products sold outside the United States. The company was founded in 1984 and is headquartered in Dublin, Ireland.

getNextHourMoveProbability failed